Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) is a combination of antidiabetic medicine (voglibose: alpha-glucosidase inhibitor; metformin: biguanide; glimepiride: sulfonylurea) used in type 2 diabetes when diet and exercise alone are insufficient. It works as a three-way helper: voglibose slows sugar absorption from food in the intestine, metformin lowers sugar made by the liver and improves insulin use, while glimepiride stimulates the pancreas to release more insulin. Common side effects include bloating, gas, nausea, diarrhea, dizziness, and low blood sugar if meals are missed. It should be taken with food to reduce stomach discomfort and hypoglycemia risk, while alcohol should be avoided due to the chance of lactic acidosis.

Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) is an oral tablet belonging to the category of antidiabetic drugs. Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) is used for management of type 2 Diabetes mellitus

More Common  

1. Abdominal or stomach discomfort  
2. Cough or hoarseness  
3. Decreased appetite  
4. Diarrhea  
5. Fast or shallow breathing  
6. Fever or chills  
7. General feeling of discomfort  
8. Lower back or side pain  
9. Muscle pain or cramping  
10. Painful or difficult urination  
11. Sleepiness 

Less Common 

1. Anxiety 
2. Blurred vision 
3. Chest discomfort 
4. Cold sweats 
5. Coma 
6. Confusion 
7. Cool, pale skin 
8. Depression 
9. Difficult or labored breathing 
10. Dizziness 
11. Fast, irregular, pounding, or racing heartbeat or pulse 
12. Feeling of warmth 
13. Headache 
14. Increased hunger 
15. Increased sweating 
16. Nausea 
17. Nervousness 
18. Nightmares 
19. Redness of the face, neck, arms, and occasionally, upper chest 
20. Seizures 
21. Shakiness 
22. Slurred speech 
23. Tightness in the chest 
24. Unusual tiredness or weakness 

Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) works by targeting three key problems in type 2 diabetes: slow insulin response, excess sugar production, and rapid sugar absorption from food. Metformin slows the rapid absorption of sugar from meals into the bloodstream, giving the body more time to handle it. Voglibose activates the pancreas to release more insulin. Glimepiride reduces the sugar production in the liver and makes the body’s cells respond better to insulin. Together, they help keep blood sugar levels steady, especially after meals.

Pregnancy

Due to a lack of studies on the effects of Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) on the fetus during pregnancy, their safety is not clearly established. Therefore, if you are pregnant or planning to conceive, inform your doctor.

Breastfeeding

Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) pass into breast milk. Tell your healthcare provider if you are breastfeeding or plan to breastfeed. Your healthcare provider will advise you if you should stop breastfeeding or stop Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR).

Kidney and Liver Problems

Patients suffering from kidney and liver problems are more prone to kidney and liver damage, as the drug is made into a less toxic form in the liver and kidney, so consult a doctor before using them.

Alcohol and smoking can simultaneously affect the drug’s action and show an effect on blood glucose levels by affecting the liver and pancreas. It can sometimes increase blood sugar levels and sometimes decrease blood sugar levels.

Avoid taking Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) with the following medicines, as it may increase or decrease the desired effect, or in worse cases, it could be fatal:

IUPAC (International Union of Pure and Applied Chemistry)/ Chemical name

Voglibose- (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol 

Glimepiride—3‑Ethyl‑4‑methyl‑N‑[2‑(4‑{[(trans‑4‑methylcyclohexyl) carbamoyl] sulfamoyl} phenyl)ethyl]‑2‑oxo‑2,5‑dihydro‑1H‑pyrrole‑1‑carboxamide

Metformin- N, N-dimethylimidodicarbonimidic diamide

Daily dose

Take Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) exactly as your doctor recommends. The dose may change based on your condition and how well you respond. Do not take more than prescribed without consulting your doctor.

Missed Dose

If you forget to take your medicine, take the medication as soon as you remember. If it’s nearly time for your next dose, skip the missed one and continue with your regular schedule. Always consult the doctor before making any changes to your dosage.

Overdose

It is not recommended to take more than 1500 mg of Metformin+ voglibose + glimepiride per day, as it may cause severe overdosing effects like extreme drowsiness, confusion, low blood pressure, unconsciousness, sweating, gastric symptoms, and seizures. Immediately take fruit or glucose-containing liquids and sugary foods to minimize the effects. If you face any of the severe effects, meet the doctor.

1. Store the medicine at room temperature 
2. Keep away from sunlight and moisture 
3. Keep out of reach of children 

1. Take Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) exactly as prescribed by your doctor, at the same time each day. 
2. Do not stop taking Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR)without your doctor’s approval, even if you feel better. 
3. If you forget to take Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR), take them as soon as you remember. If it’s almost time for your next dose, skip the missed dose.

What are the uses of the Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) combination tablet? 

Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) are used together to control blood sugar in type 2 diabetes when diet and exercise aren’t enough. They work by slowing sugar absorption, boosting insulin release, and reducing sugar production in the liver.

What are the side effects of Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) tablets? 

Common side effects of Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) include bloating, gas, nausea, diarrhea, dizziness, headache, and low blood sugar, especially if meals are skipped. Rarely, metformin may cause lactic acidosis, a serious condition so alcohol should be avoided.

Does the Voglibose 0.2 mg + Glimepiride 1 mg + Metformin 500 mg (SR) combination medicine cause weight loss? 

Metformin may help with modest weight loss by improving insulin sensitivity and reducing appetite. Voglibose has a neutral effect on weight, while glimepiride may cause weight gain due to increased insulin levels. So overall, this combination is not typically used for weight loss, and its effect on weight can vary from person to person.

1. Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Br J Diabetes Vasc Dis. 2008;8(3):121-7. Available from. 
2. Drugs.com. Voglibose [Internet]. Drugs.com International. [cited 2025 Aug 14]. Available from. 
3. DrugBank Online. Voglibose [Internet]. Edmonton (AB): DrugBank; [cited 2025 Aug 14]. Available from. 
4. Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. 10th ed. Philadelphia: Elsevier; 2017. Chapter 25, The Endocrine System [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); [cited 2025 Aug 14]. Available from. 
5. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2024 Jan–. Available from. 
6. Drug Bank. Metformin [Internet]. Edmonton (AB): Drug Bank; [cited 2025 Jul 18]. Available from. 
7. WebMD. Metformin oral [Internet]. New York (NY): WebMD LLC; ©1996–2025 [cited 2025 Jul 18]. Available from. 
8. Drugs.com. Metformin [Internet]. ©1996–2025 [cited 2025 Jul 18]. Available from. 
9. PubChem. Glimepiride [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; [cited 2025 Sep 23]. Available from. 
10. Mayo Clinic. Glimepiride (oral route): Side effects and dosage [Internet]. Rochester (MN): Mayo Foundation for Medical Education and Research; c2025 [cited 2025 Sep 23]. Available from. 
11. Drugs.com. Glimepiride: Uses, side effects and warnings [Internet]. Drugs.com; c1996‑2025 [cited 2025 Sep 23]. Available from.